Forte Biosciences Inc expected to post a loss of 17 cents a share - Earnings Preview

Forte Biosciences

09/08/2024 17:11

* Forte Biosciences Inc  FBRX.OQ   FBRX.O  is expected
to report
resultson August 12 (estimated) for the period ending June
30 2024
    * 
    * ​LSEG's mean analyst estimate for Forte Biosciences Inc is
for a
loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Forte
Biosciences
Inc is $3.00​, above​ its last closing price of $0.43. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.17       -0.16      -0.16     Met     3
 Dec. 31 2024              -0.28      -0.19     Beat    33.6
                                                        ​
 ​​                                                     
                                      -0.23             ​
 Sep. 30 2022  -0.15       -0.15      -0.18     Missed  -20
 This summary was machine generated August 9 at 16:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)